This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Trodelvy (sacituzumab govitecan-hziy)
General Description:
Trodelvy (sacituzumab govitecan-hziy) is an intravenous targeted therapy used for the treatment of:
- Metastatic triple-negative breast cancer (mTNBC) in patients who have received at least two prior therapies for metastatic disease
- Bladder cancer or cancers of the urinary tract that are metastatic or unresectable, in patients previously treated with platinum-based chemotherapy and immunotherapy
- HR-positive, HER2-negative metastatic breast cancer that is unresectable, in patients who have received endocrine therapy and at least two additional treatments for metastatic disease
Trodelvy works by delivering a cytotoxic agent directly to cancer cells expressing Trop-2, slowing tumor growth and improving outcomes. Treatment is administered under the supervision of a qualified oncologist, with dosage tailored to patient needs.
Getting Trodelvy (sacituzumab govitecan-hziy) in India
Trodelvy is approved by international regulatory agencies including the FDA (U.S.), EMA (Europe), and PMDA (Japan). While it may not yet be commercially available in India, patients can access it legally through a Named Patient Program (NPP) under the guidance of a licensed physician.
MitoGENE supports Indian patients in obtaining Trodelvy safely, managing all regulatory approvals, import permits, and logistics for a compliant and secure process.
Disease Indication:
• Urothelial Carcinoma / Bladder Cancer
• Breast Cancer / Metastatic Triple-Negative or HR-positive/HER2-negative
Manufacturer:
Immunomedics Inc.
Usage:
Intravenous
Medicine Approved By:
• Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• Pharmaceuticals and Medical Devices Agency (PMDA)
Available Dosage Form & Package:
• Single-dose vial: 180 mg
• Single-dose vial: 200 mg
Shipping:
Cold Chain Shipping
Trodelvy requires cold chain shipping to protect it from heat, light, and handling. Specialized medical couriers use temperature-controlled packaging and vehicles to maintain stability and effectiveness, ensuring the medicine remains safe for patient use.
How to Access Trodelvy (sacituzumab govitecan-hziy) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Trodelvy (sacituzumab govitecan-hziy) is not yet approved or commercially available in India, MitoGENE can assist you in accessing it legally through the Named Patient Program (NPP). Here’s how the process works:
